These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21233692)

  • 1. Anaphylactic reaction to different gonadotropin-releasing hormone agonists for the treatment of endometriosis.
    Lüchinger AB; Mijatovic V; Rustemeyer T; Hompes PG
    Am J Med Sci; 2011 Mar; 341(3):240-2. PubMed ID: 21233692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis].
    Song JH; Lu H; Zhang J; Li B
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent anaphylaxis associated with gonadotropin-releasing hormone analogs: case report and review of the literature.
    Lam C; Tjon J; Hamilton J; Ahmet AH
    Pharmacotherapy; 2006 Dec; 26(12):1811-5. PubMed ID: 17125443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to luteinizing hormone releasing hormone agonist therapy for metastatic prostate cancer.
    Curry EA; Sweeney CJ
    J Urol; 2002 Jul; 168(1):193. PubMed ID: 12050525
    [No Abstract]   [Full Text] [Related]  

  • 5. Depressive symptoms associated with gonadotropin-releasing hormone agonists.
    Warnock JK; Bundren JC; Morris DW
    Depress Anxiety; 1998; 7(4):171-7. PubMed ID: 9706454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent anaphylaxis to a depot form of GnRH analogue.
    Letterie GS; Stevenson D; Shah A
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):943-6. PubMed ID: 1923237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of pelvic endometriosis with goserelin, an LHRH agonist].
    Ventruba P; Crha I; Müller P; Mlyncek M
    Ceska Gynekol; 1996 Feb; 61(1):11-6. PubMed ID: 8624587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple polypoid endometriosis--a rare complication following withdrawal of gonadotrophin releasing hormone (GnRH) agonist for severe endometriosis: a case report.
    Othman NH; Othman MS; Ismail AN; Mohammad NZ; Ismail Z
    Aust N Z J Obstet Gynaecol; 1996 May; 36(2):216-8. PubMed ID: 8798320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Time to normalization of testosterone after withdrawal of long time LH-RH agonist therapy in prostate cancer].
    Kaku H; Tsushima T; Nasu Y; Kumon H
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():182-7. PubMed ID: 12599568
    [No Abstract]   [Full Text] [Related]  

  • 10. Case report: systemic hypersensitivity reaction to goserelin acetate.
    Raj SG; Karadsheh AJ; Guillot RJ; Raj MH; Kumar P
    Am J Med Sci; 1996 Oct; 312(4):187-90. PubMed ID: 8853068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endometriosis: clinical, histological and morphometric findings before and after Gn-RH agonist therapy].
    Ruwe M; Donhuijsen K; Regidor PA; Leder LD; Schindler AE
    Zentralbl Gynakol; 1998; 120(8):391-8. PubMed ID: 9757546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
    Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
    Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
    Takaesu Y; Nishi H; Kojima J; Sasaki T; Nagamitsu Y; Kato R; Isaka K
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1152-8. PubMed ID: 27225336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer.
    Smith MR; Boyce SP; Moyneur E; Duh MS; Raut MK; Brandman J
    J Urol; 2006 Jan; 175(1):136-9; discussion 139. PubMed ID: 16406890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient developing anaphylaxis and sensitivity to two different GnRH analogues and a review of literature.
    Ökdemir D; Hatipoğlu N; Akar HH; Gül Ü; Akın L; Tahan F; Kurtoğlu S
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):923-5. PubMed ID: 25719301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options of endometriosis prior to in vitro fertilization/intracytoplasmic sperm injection cycles to improve conception rate.
    Prasad S; Bassi R; Kumar Y; Kumar A; Prasad S
    Taiwan J Obstet Gynecol; 2015 Jun; 54(3):316-8. PubMed ID: 26166349
    [No Abstract]   [Full Text] [Related]  

  • 17. [Short-term outcome of leuprorelin acetate in preventing recurrence of ovarian endometrioma after conservative surgery].
    Yuan L; Wu QJ; Liu XS
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):508-10. PubMed ID: 24284221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial.
    Miller JD
    Am J Obstet Gynecol; 2000 Jun; 182(6):1483-8. PubMed ID: 10871469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Using GnRH-agonists (Zoladex) in the treatment of genital endometriosis].
    Nikolov A; Tiufekchieva E; Novachkov V; Karag'ozov I
    Akush Ginekol (Sofiia); 2006; 45(4):13-20. PubMed ID: 16889194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal endometriosis complicated by ileal perforation after initiation of gonadotropin-releasing hormone agonist therapy.
    Saito S; Murakami T; Suzuki K; Terada Y; Fukushima K; Moriya T
    Fertil Steril; 2007 Oct; 88(4):969.e7-9. PubMed ID: 17493620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.